Why the study?
Does prorenin receptor blockade prevent diabetic nephropathy in diabetic Angiotensin II type 1a receptor-deficient mice?
Population
Wild-type mice and Angiotensin II type 1a receptor gene-deficient mice with diabetes induced by…
Comparison
Prolonged prorenin receptor blockade with a… vs Prolonged inhibition of angiotensin-converting…
Design
Preclinical
Authors
Loading...
Hypothesis-generating in diabetic mice; leaves open prorenin receptor blockade as an AngII-independent target pending human trials.
Does prorenin receptor blockade prevent diabetic nephropathy in diabetic Angiotensin II type 1a receptor-deficient mice?
Prorenin receptor blockade prevents diabetic nephropathy via an AngII-independent mechanism involving MAPK activation, suggesting a novel therapeutic target.
Ichihara et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: